Astragaloside IV Attenuates Chronic Prostatitis by Activating Keap1/Nrf2/HO-1 Pathway: Suppressing Ferroptosis and Enhancing Antioxidant Defense
Jintao Shi,1,* Yang Xuan,1– 3,* Qinyu Zhang,1,* Jiangtao Chen,1 Weihan Zhu,1 Hao Zhang,2,3 Yue Duan2,3 1The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, People’s Republic of China; 2Department of Urology and And...
Saved in:
Main Authors: | Shi J, Xuan Y, Zhang Q, Chen J, Zhu W, Zhang H, Duan Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-07-01
|
Series: | Journal of Inflammation Research |
Subjects: | |
Online Access: | https://www.dovepress.com/astragaloside-iv-attenuates-chronic-prostatitis-by-activating-keap1nrf-peer-reviewed-fulltext-article-JIR |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Melatonin Activates KEAP1/NRF2/PTGS2 Pathway to Attenuate Hyperoxia-Driven Ferroptosis in Bronchopulmonary Dysplasia
by: Deng X, et al.
Published: (2025-06-01) -
Nrf1 acts as a highly-conserved determinon for maintaining robust redox homeostasis in the eco-evo-devo process of life histories
by: Yiguo Zhang, et al.
Published: (2025-07-01) -
Anthrahydroquinone-2,6-Disulfonate Restores Lung Function in COPD Through Keap1/Nrf2 Pathway Activation
by: Li Z, et al.
Published: (2025-07-01) -
Design, Synthesis, and Evaluation of Nitroxide Radical Derivatives Based on Rhein as Potential Anti-Aging Agents Targeting the Keap1-Nrf2 Pathway
by: Wang J, et al.
Published: (2025-06-01) -
Modulation of the KEAP1-NRF2 pathway by Erianin: A novel approach to reduce psoriasiform inflammation and inflammatory signaling
by: Yan Hongmei, et al.
Published: (2025-07-01)